BMC Medicine

BMC Medicine is a premier, open-access, peer-reviewed medical journal published by BioMed Central (part of Springer Nature). With an ISSN of 1741-7015 and an abbreviation of BMC MED, the journal holds a distinguished position in the field, evidenced by its 2026 Journal Impact Factor of 8.700 and its placement in the JCR Q1 quartile. The journal’s scope is broad and inclusive, covering all areas of clinical medicine, translational research, public health, and global health. It prioritizes studies that offer significant advances in the understanding, diagnosis, treatment, or prevention of human disease, with a strong emphasis on research that has direct clinical or policy implications. BMC Medicine publishes a diverse array of article types, including original research articles, systematic reviews, meta-analyses, research protocols, commentaries, and debate pieces. It is particularly known for its high-quality, data-rich research and its commitment to methodological rigor and reproducibility. The target audience is primarily clinicians, biomedical researchers, public health professionals, and healthcare policymakers seeking authoritative, evidence-based findings that can inform practice and future investigation. A defining feature of BMC Medicine is its fully open-access model, ensuring that all published content is freely and permanently available online to anyone, anywhere, thereby maximizing the dissemination and impact of the research it publishes. As a Q1 journal with an impact factor well above 8.0, BMC Medicine is widely regarded as one of the leading general medical journals, consistently ranking among the top titles in its category and serving as a trusted source for high-impact, clinically relevant science.